Listed

Processa Pharmaceuticals, Inc.

PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Processa Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2024-10-0216:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-039220
2024-08-2808:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-034115
2024-08-1316:15 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-031622
2024-07-3008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-029514
2024-07-1708:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-028093
2024-07-0219:44 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-025884
2024-05-2116:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-24-020883
2024-05-1016:16 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018648
2024-04-2916:30 ETDEF 14AProxy statementPeriod 2024-04-290001493152-24-016998
2024-04-1108:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-014278
2024-04-0412:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-013132
2024-03-2916:06 ET10-KAnnual reportPeriod 2023-12-310001493152-24-011976
2024-02-2117:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-007444
2024-02-0608:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-005029
2024-01-3010:46 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-004251
2024-01-2508:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-003705
2024-01-2218:08 ETS-1/ARegistration statement, amended0001493152-24-003101
2024-01-1908:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-002983
2024-01-1808:30 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-24-002835
2024-01-0816:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-001713
2023-12-2908:55 ETS-1Registration statement0001493152-23-046483
2023-12-1909:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-045362
2023-12-0517:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-043743
2023-11-1615:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-041652
2023-11-1511:30 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-041422
2023-11-1316:00 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-040472
2023-11-1314:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-040439
2023-10-1609:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-037299
2023-10-0510:00 ETDEF 14AProxy statementPeriod 2023-10-050001493152-23-035761
2023-09-2117:29 ET8-K3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-23-033372
2023-08-1712:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-029250
2023-08-1016:16 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-027551
2023-08-0810:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-027122
2023-06-2916:18 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-022920
2023-06-2112:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-021934
2023-05-2414:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018883
2023-05-1815:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018082
2023-05-1510:00 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-017001
2023-05-0821:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-015708
2023-05-0110:00 ETDEF 14AProxy statementPeriod 2023-05-010001493152-23-014884
2023-03-3108:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-009935
2023-03-3016:01 ET10-KAnnual reportPeriod 2022-12-310001493152-23-009730
2023-03-2216:30 ET8-K3.01 Delisting notice0001493152-23-008547
2023-03-1412:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-007564
2023-02-1316:05 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-004481
2023-02-0608:00 ET8-K8.01 Other events0001493152-23-003631
2023-01-0909:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-000912
2022-12-2214:53 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-036285
2022-12-1411:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-035400
2022-11-0816:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-030944

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.